Method and device for treating abnormal tissue growth with electrical therapy
This invention relates generally to the electrical treatment of malignant tumors and neoplasms by applying a voltage to affected tissue. Devices and various adaptations therein are described for use in electrical therapy. Additionally, various chemotherapeutic agent and radiation therapies are described which may be advantageously used in conjunction with electrical therapy to ameliorate cancer.
1. An apparatus for treating abnormal tissue growth in a patient's body comprising:
a battery; and
circuitry coupled to said battery, said circuitry capable of generating electrical pulses at varying duty cycles; and
at least one electrode operably coupled to said circuitry wherein said circuitry delivers electrical pulses at a variable duty cycle of less than 100 percent to said at least one electrode for the ablation of the abnormal tissue growth, wherein the variable duty cycle cycles between:
an on period in which electrical energy is applied to the abnormal tissue growth and surrounding tissue by said at least one electrode to induce a pH change in the abnormal tissue and surrounding tissue, and
an off period allowing the pH of the surrounding tissue to return to original levels.
2. The device of claim 1 wherein said variable duty cycle is achieved by the circuitry providing a varying pulse width.
3. The device of claim 1 wherein said variable duty cycle is achieved by the circuitry providing a varying pulse frequency.
4. The device of claim 1 wherein said duty cycle is in the range of 50 to 70 percent.
5. The device of claim 1 wherein the electrode delivers between 1 volt and 20 volts to the abnormal tissue.
6. The device of claim 1 wherein the electrode delivers between 20 mV and 500 mV to the abnormal tissue.
7. The device of claim 1 wherein the circuitry varies the pulse width within the range of 100 μs and 20 ms.
8. The device of claim 1 wherein the electrode delivers a series of between 1 and 10,000 electrical pulses with a spacing period of between 100 μs and 1 second.
9. The device of claim 1 wherein the electrode delivers between about 0.5 to about 50 mA for 1-50 hours, followed by a rest period of between 1 and 72 hours.
10. An apparatus comprising:
an implantable device housing; and
a battery having a maximum output wherein said battery is contained within said device housing; and
circuitry contained within said device housing wherein said circuitry is coupled to said battery, said circuitry capable of generating electrical pulses at varying pulse widths and frequencies; and
at least one electrode operably coupled to said circuitry wherein said circuitry delivers electrical pulses at a variable output less than said battery maximum output for the treatment of abnormal tissue growths, wherein the electrode cycles between:
an on period in which electrical energy is applied to the abnormal tissue growth and surrounding tissue to induce a pH change in the abnormal tissue and surrounding tissue, and
an off period allowing the pH of the surrounding tissue to return to original levels.
11. The device of claim 10 wherein said electrical therapy at a variable output less than said battery maximum output is achieved by a variable duty cycle of less than 100 percent.
12. The device of claim 11 wherein said variable duty cycle of less than 100 percent is achieved by modifying pulse width over time.
13. The device of claim 11 wherein said duty cycle of less than 100 percent is achieved by modifying frequency over time.
14. The device of claim 11 wherein said duty cycle is in the range of 50 to 70 percent.
15. The device of claim 9 wherein the electrode delivers between 1 volt and 20 volts to the abnormal tissue.
16. The device of claim 10 wherein the electrode delivers between 20 mV and 500 mV to the abnormal tissue.
17. The device of claim 10 wherein the circuitry varies the pulse width within the range of 100 μs and 20 ms.
18. The device of claim 10 wherein the electrode delivers a series of between 1 and 10,000 electrical pulses with a spacing period of between 100 μs and 1 second.
19. The device of claim 10 wherein the electrode delivers between about 0.5 to about 50 mA for 1-50 hours, followed by a rest period of between 1 and 72 hours.
20. An apparatus for treating abnormal tissue growth in a patient's body comprising:
a battery;
a control unit external to the patient's body;
circuitry coupled to said battery and to said control unit and configured to deliver electrical pulses to at least one electrode, said electrode operably coupled to said circuitry and implanted into the patient's body near the abnormal tissue;
said control unit being configured to cause said circuitry to deliver electrical pulses at a duty cycle that automatically varies over time to said at least one electrode for the ablation of the abnormal tissue growth, wherein the control unit cycles between:
an on period in which electrical energy is applied to the abnormal tissue growth and surrounding tissue to induce a pH change in the abnormal tissue and surrounding tissue, and
an off period allowing the pH of the surrounding tissue to return to original levels.
21. The device of claim 20 wherein the control until is configured to automatically vary the pulse width over time of electrical pulses delivered from the circuitry.
22. The device of claim 21 wherein the circuitry varies the pulse width within the range of 100 ps and 20 ms.
23. The device of claim 21 wherein the electrode delivers a series of between 1 and 10,000 electrical pulses with a spacing period of between 100 ps and 1 second.
24. The device of claim 20 wherein the control unit is configured to automatically vary the pulse frequency over time of electrical pulses delivered from the circuitry.
25. The device of claim 20 wherein said duty cycle is in the range of 50 to 70 percent.
26. The device of claim 20 wherein the electrode delivers between about 0.5 to about 50 mA for 1-50 hours, followed by a rest period of between 1 and 72 hours.
27. The device of claim 20 wherein the control unit is a laptop computer.
28. The device of claim 20 wherein the control unit is coupled to said circuitry through a telemetry unit.